Go Pro

Allogene Therapeutics (ALLO) News Today

Allogene Therapeutics logo
$2.16 +0.14 (+6.65%)
As of 02:46 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Allogene Therapeutics Latest News

Allogene (ALLO) Q2 2026 Earnings Call Transcript
Allogene Therapeutics, Inc. Q2 2026 Earnings Call Summary
Allogene Therapeutics Q2 Earnings Call Highlights
Allogene Therapeutics Announces Planned CEO Succession
Allogene Therapeutics Q1 2026 Earnings Call Transcript

Allogene Therapeutics Media Mentions By Week

Allogene Therapeutics Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ALLO
News Sentiment

0.80

0.67

Average
Healthcare
News Sentiment

Allogene Therapeutics News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ALLO Articles
This Week

4

4

ALLO Articles
Average Week

Allogene Therapeutics Trends on MarketBeat

This week vs. last week
New Followers
2
-33%
Searches
1
-50%
Page Views
2,857
-8%
Get Allogene Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ALLO and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Allogene Therapeutics dated 8/25/2026.
From Our Partners